News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,234 Results
Type
Article (39742)
Company Profile (248)
Press Release (660244)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204191)
Career Advice (2008)
Deals (35423)
Drug Delivery (95)
Drug Development (81056)
Employer Resources (172)
FDA (16189)
Job Trends (14864)
News (345235)
Policy (32547)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (49444)
ALS (96)
Alzheimer's disease (1385)
Antibody-drug conjugate (ADC) (133)
Approvals (16187)
Artificial intelligence (265)
Autoimmune disease (22)
Automation (17)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (176)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (293)
Cancer (2328)
Cardiovascular disease (180)
Career advice (1677)
Career pathing (30)
CAR-T (159)
Cell therapy (443)
Cervical cancer (20)
Clinical research (66107)
Collaboration (859)
Company closure (2)
Compensation (572)
Complete response letters (19)
COVID-19 (2590)
CRISPR (41)
C-suite (252)
Cystic fibrosis (102)
Data (2353)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (275)
Diagnostics (6384)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (105)
Drug shortages (25)
Duchenne muscular dystrophy (98)
Earnings (87151)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (112702)
Executive appointments (746)
FDA (17579)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (777)
Gene editing (109)
Generative AI (20)
Gene therapy (318)
GLP-1 (720)
Government (4432)
Grass and pollen (4)
Guidances (169)
Healthcare (18820)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (125)
Indications (29)
Infectious disease (2735)
Inflammatory bowel disease (143)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (99)
Interviews (312)
IPO (16531)
IRA (40)
Job creations (3633)
Job search strategy (1422)
Kidney cancer (10)
Labor market (43)
Layoffs (475)
Leadership (17)
Legal (7910)
Liver cancer (76)
Lung cancer (326)
Lymphoma (159)
Machine learning (9)
Management (58)
Manufacturing (329)
MASH (78)
Medical device (13389)
Medtech (13394)
Mergers & acquisitions (19474)
Metabolic disorders (710)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (95)
Neuropsychiatric disorders (27)
Neuroscience (1949)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (40)
Obesity (372)
Opinion (205)
Ovarian cancer (81)
Pain (91)
Pancreatic cancer (88)
Parkinson's disease (154)
Partnered (22)
Patents (245)
Patient recruitment (116)
Peanut (46)
People (57358)
Pharmaceutical (63)
Pharmacy benefit managers (20)
Phase I (20601)
Phase II (29120)
Phase III (21678)
Pipeline (1432)
Policy (147)
Postmarket research (2563)
Preclinical (8764)
Press Release (64)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (386)
Real estate (5908)
Recruiting (65)
Regulatory (22332)
Reports (48)
Research institute (2321)
Resumes & cover letters (349)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (72)
Series A (133)
Series B (91)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3581)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (51)
The Weekly (30)
Vaccines (699)
Venture capitalists (42)
Weight loss (237)
Women's health (36)
Worklife (16)
Date
Today (201)
Last 7 days (949)
Last 30 days (3353)
Last 365 days (32516)
2025 (12124)
2024 (35219)
2023 (40076)
2022 (51175)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35019)
2017 (32110)
2016 (31481)
2015 (37554)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (37886)
Australia (6195)
California (6482)
Canada (2077)
China (539)
Colorado (275)
Connecticut (282)
Delaware (159)
Europe (81435)
Florida (963)
Georgia (217)
Idaho (57)
Illinois (549)
India (25)
Indiana (323)
Iowa (11)
Japan (173)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (927)
Massachusetts (4812)
Michigan (226)
Minnesota (406)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (68)
New Hampshire (63)
New Jersey (1803)
New Mexico (28)
New York (1821)
North Carolina (993)
North Dakota (8)
Northern California (2871)
Ohio (210)
Oklahoma (14)
Oregon (34)
Pennsylvania (1438)
Puerto Rico (13)
Rhode Island (33)
South America (1097)
South Carolina (26)
South Dakota (1)
Southern California (2433)
Tennessee (107)
Texas (962)
United States (24221)
Utah (188)
Virginia (153)
Washington D.C. (64)
Washington State (569)
West Virginia (3)
Wisconsin (58)
700,234 Results for "humacyte inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
March 26, 2025
·
7 min read
Press Releases
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
March 26, 2025
·
7 min read
Press Releases
Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
·
18 min read
Press Releases
Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025
May 9, 2025
·
2 min read
Press Releases
Trestle Bio Announces Research Collaboration with Humacyte
March 6, 2025
·
4 min read
Regulatory
FDA Needs More Time to Review Humacyte’s Blood Vessel Implant
Humacyte’s stock price dropped 18% in after-hours trading Friday after the company announced the FDA requires additional time to review its Biologic License Application. No reason was given for the delay or an updated decision date.
August 12, 2024
·
1 min read
·
Tristan Manalac
Press Releases
Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update
March 31, 2025
·
19 min read
Press Releases
Humacyte to Present at the TD Cowen 45th Annual Health Care Conference
February 27, 2025
·
5 min read
Press Releases
Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025
March 27, 2025
·
2 min read
Bio NC
Humacyte to Participate at Upcoming Investor Conferences in May
Humacyte, Inc. today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, Dale Sander, Chief Financial Officer, and B.J. Scheessele, Chief Commercial Officer, will represent Humacyte at the following conferences in May.
May 13, 2024
·
2 min read
1 of 70,024
Next
